INO
Inovio Pharmaceuticals, Inc.Closed0.9982−0.11 −9.67%USD
NasdaqCM · as of Oct 13, 16:00 ET · 15m delayAfter hours 1.01 +1.18%
Open
1.11
Prev close
1.11
Day range
0.95001.11
52-week range
0.56002.72
Volume
8.46M2.15×
Mkt cap
103.21M
P/E ttm
—
Fwd P/E
-2.27
EPS ttm
-0.9000
Div yield
0.00%
Earnings
Aug 12, 2026
From 52w high
−63.30%
INO earnings and estimates
INO Next Report
Yahoo Finance · Nasdaq
Report date
Tue, Nov 10
After the close · estimated
EPS consensus
$−0.20
range −0.20 – −0.19
EPS growth vs year ago
+77.6%
year ago −0.87
Revenue consensus
$0
0.0% vs year ago
Options-implied move
—
no expiry soon after the report
Past 4 reactions
±6.6%
average move · beat 3 of 4
EPS: Actual vs Estimate
Price Reaction
close before → close after the report
Recent Reports
| Quarter ending | Reported | EPS | Estimate | Surprise | Revenue | Next session | Five sessions |
|---|---|---|---|---|---|---|---|
| Jun '26 | Aug 12, 2026 AMC | −0.24 | −0.24 | +0.57% | — | +16.9% | +68.8% |
| Mar '26 | May 13, 2026 AMC | −0.31 | −0.33 | +4.71% | $0 | +1.5% | −8.2% |
| Dec '25 | Mar 12, 2026 AMC | −0.28 | −0.34 | +19.59% | $0 | −1.2% | −1.8% |
| Sep '25 | Nov 10, 2025 AMC | −0.87 | −0.48 | −82.77% | $0 | −7.0% | −7.9% |
Consensus Estimates and Revisions
| Period | EPS | Low · range · high | Growth | Revenue | Growth | 30d ago | 90d ago | Up / down (30d) |
|---|---|---|---|---|---|---|---|---|
| Current quarter Sep 2026 | −0.20 | −0.20−0.19 | +77.6% | $0 | 0.0% | −0.25 +20.9% | −0.24 +19.6% | 2 / 0 |
| Next quarter Dec 2026 | −0.18 | — | +35.1% | $666.67K | 0.0% | −0.16 −12.5% | −0.16 −10.8% | 2 / 0 |
| Current year Dec 2026 | −0.73 | — | +59.9% | $666.67K | +920.3% | −1.14 +36.0% | −1.04 +30.0% | 1 / 0 |
| Next year Dec 2027 | −0.44 | −0.67−0.21 | +39.7% | $50.61M | +7490.8% | −0.41 −7.3% | −0.56 +21.9% | 2 / 0 |
The change columns show how the consensus has moved since then; steady upward revisions often precede beats. Ranges place the consensus between the lowest and highest analyst estimate.
Forward EPS Forecasts
Nasdaq · Zacks consensus
Quarterly
| Fiscal period | Consensus | Low · range · high | Analysts | Up / down (4w) |
|---|---|---|---|---|
| Sep 2026 | −0.20 | −0.20−0.19 | 2 | 0 / 0 |
| Dec 2026 | −0.18 | — | 2 | 0 / 0 |
| Mar 2027 | −0.18 | −0.20−0.15 | 2 | 0 / 0 |
| Jun 2027 | −0.13 | −0.18−0.08 | 2 | 0 / 0 |
| Sep 2027 | −0.09 | −0.16−0.03 | 2 | 0 / 0 |
Fiscal years
| Fiscal period | Consensus | Low · range · high | Analysts | Up / down (4w) |
|---|---|---|---|---|
| Dec 2026 | −0.72 | −0.73−0.71 | 2 | 0 / 0 |
| Dec 2027 | −0.44 | −0.67−0.21 | 2 | 0 / 0 |
Reactions run from the last close before a report to the first close after it (an after-the-close report is measured to the next day's close). The implied move is the at-the-money straddle for the first expiry after the report, the same rule as the bot's lgf emove.